Investor Relations
Latest Financial Results
Q2 2024 Quarterly Results
Quarter Ended Mar 31, 2024
Quarter Ended Mar 31, 2024
Sign up today and receive company updates straight to your inbox.
Firm | Analyst |
---|---|
Jefferies | Dennis Ding |
Oppenheimer | Leland Gershell |
H.C. Wainwright | Yi Chen |
Raymond James | Gary Nachman |
Veru Inc.
2916 N. Miami Avenue
Suite 1000
Miami, FL 33127
United States
T: 305-509-6897
veruinvestor@verupharma.com
Samuel Fisch
Executive Director, Investor Relations and Corporate Communications
Veruinvestor@verupharma.com